Stockreport

Oncology Could Give Gutsy Biotechs Another Chance [Seeking Alpha]

Seres Therapeutics, Inc.  (MCRB) 
Last seres therapeutics, inc. earnings: 11/5 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.serestherapeutics.com
PDF Companies focusing on the gut microbiome were dealt a serious blow last year with Seres’ (NASDAQ: MCRB ) phase II failure, but now a small study could reinvigorate [Read more]